217 related articles for article (PubMed ID: 29614360)
21. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
Jereczek-Fossa BA; Beltramo G; Fariselli L; Fodor C; Santoro L; Vavassori A; Zerini D; Gherardi F; Ascione C; Bossi-Zanetti I; Mauro R; Bregantin A; Bianchi LC; De Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):889-97. PubMed ID: 21277113
[TBL] [Abstract][Full Text] [Related]
22. Recurrent malignant gliomas.
Kirkpatrick JP; Sampson JH
Semin Radiat Oncol; 2014 Oct; 24(4):289-98. PubMed ID: 25219814
[TBL] [Abstract][Full Text] [Related]
23. Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas.
Minniti G; Agolli L; Falco T; Scaringi C; Lanzetta G; Caporello P; Osti MF; Esposito V; Enrici RM
J Neurooncol; 2015 May; 122(3):559-66. PubMed ID: 25702193
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment.
Alan O; Telli TA; Basoğlu T; Arikan R; Demircan NC; Ercelep O; Bozkurt S; Atasoy BM; Dane F; Yumuk PF
Clin Neurol Neurosurg; 2020 Sep; 196():105976. PubMed ID: 32531614
[TBL] [Abstract][Full Text] [Related]
25. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Arvold ND; Shi DD; Aizer AA; Norden AD; Reardon DA; Lee EQ; Nayak L; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Wen PY; Alexander BM
J Neurooncol; 2017 Dec; 135(3):581-591. PubMed ID: 28975467
[TBL] [Abstract][Full Text] [Related]
26. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
27. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
Shi W; Blomain ES; Siglin J; Palmer JD; Dan T; Wang Y; Werner-Wasik M; Glass J; Kim L; Bar Ad V; Bhamidipati D; Evans JJ; Judy K; Farrell CJ; Andrews DW
J Neurooncol; 2018 Mar; 137(1):171-177. PubMed ID: 29235052
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).
Laing RW; Warrington AP; Graham J; Britton J; Hines F; Brada M
Radiother Oncol; 1993 Apr; 27(1):22-9. PubMed ID: 8327729
[TBL] [Abstract][Full Text] [Related]
29. Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma.
Cha Y; Kim YJ; Lee SH; Kim TM; Choi SH; Kim DW; Park CK; Kim IH; Kim JH; Kim E; Choi B; Kim CY; Kim IA; Heo DS
Cancer Res Treat; 2017 Jan; 49(1):129-140. PubMed ID: 27188199
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
[TBL] [Abstract][Full Text] [Related]
31. Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma.
Bergman D; Modh A; Schultz L; Snyder J; Mikkelsen T; Shah M; Ryu S; Siddiqui MS; Walbert T
J Neurooncol; 2020 Jun; 148(2):353-361. PubMed ID: 32444980
[TBL] [Abstract][Full Text] [Related]
32. [Clinical efficacy of stereotactic radiation therapy combined with temozolomide on recurrent brain glioma].
Zhao H; Liu S; Jiang C; Li X; Tang S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):394-397. PubMed ID: 29774875
[TBL] [Abstract][Full Text] [Related]
33. Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy.
Kim B; Soisson E; Duma C; Chen P; Hafer R; Cox C; Cubellis J; Minion A; Plunkett M; Mackintosh R
Clin Neurol Neurosurg; 2011 Jul; 113(6):509-12. PubMed ID: 21392883
[TBL] [Abstract][Full Text] [Related]
34. Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study.
Dodoo E; Huffmann B; Peredo I; Grinaker H; Sinclair G; Machinis T; Enger PO; Skeie BS; Pedersen PH; Ohlsson M; Orrego A; Kraepelien T; Barsoum P; Benmakhlouf H; Herrman L; Svensson M; Lippitz B
World Neurosurg; 2014 Nov; 82(5):e623-32. PubMed ID: 24930898
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.
Kong DS; Lee JI; Park K; Kim JH; Lim DH; Nam DH
Cancer; 2008 May; 112(9):2046-51. PubMed ID: 18338759
[TBL] [Abstract][Full Text] [Related]
36. Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients.
Niyazi M; Jansen NL; Rottler M; Ganswindt U; Belka C
Radiat Oncol; 2014 Dec; 9():299. PubMed ID: 25529015
[TBL] [Abstract][Full Text] [Related]
37. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
Schwer AL; Damek DM; Kavanagh BD; Gaspar LE; Lillehei K; Stuhr K; Chen C
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):993-1001. PubMed ID: 17967517
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
Marcus KJ; Goumnerova L; Billett AL; Lavally B; Scott RM; Bishop K; Xu R; Young Poussaint T; Kieran M; Kooy H; Pomeroy SL; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):374-9. PubMed ID: 15667955
[TBL] [Abstract][Full Text] [Related]
39. A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
Wuthrick EJ; Curran WJ; Camphausen K; Lin A; Glass J; Evans J; Andrews DW; Axelrod R; Shi W; Werner-Wasik M; Haacke EM; Hillman GG; Dicker AP
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):369-75. PubMed ID: 25104067
[TBL] [Abstract][Full Text] [Related]
40. Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.
Abbassy M; Missios S; Barnett GH; Brewer C; Peereboom DM; Ahluwalia M; Neyman G; Chao ST; Suh JH; Vogelbaum MA
Neurosurgery; 2018 Sep; 83(3):385-392. PubMed ID: 28973311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
